StockWatch
·
Other Pharmaceuticals
InvestmentMay 15, 2026, 05:13 PM

Synergy CHC Files S-1 for Resale of 101.7M Shares; May Raise $36M

AI Summary

Synergy CHC Corp. filed an S-1 registration statement for the resale of up to 101,710,000 shares of common stock by Hudson Global Ventures, LLC, including 100 million ELOC Shares and 1.54 million Warrant Shares. While the company will not receive proceeds from the resale, it may receive up to $36 million from the Equity Purchase Agreement. For the year ended December 31, 2025, the company reported $30.4 million in revenue and a net loss of $12.3 million, a decline from the prior year's performance.

Key Highlights

  • Synergy CHC filed an S-1 to register up to 101,710,000 common shares for resale by Hudson Global Ventures, LLC.
  • The company may receive up to $36,000,000 in gross proceeds under the Equity Purchase Agreement.
  • Revenue for the year ended December 31, 2025, was $30.4 million, down from $34.8 million in 2024.
  • Net loss for 2025 was $12.3 million, compared to a $2.1 million net income in 2024.
  • EBITDA for 2025 was $(6.2) million, a decrease from $6.5 million in 2024.
  • FOCUSfactor brand accounted for 92% of net revenue in 2025, totaling $27.8 million.
  • Working capital improved to a $1.8 million surplus in 2025 from a $1.1 million deficit in 2024.